Activating and inhibitory receptors of natural killer cells
- PMID: 20567250
- DOI: 10.1038/icb.2010.78
Activating and inhibitory receptors of natural killer cells
Abstract
Natural killer (NK) cells are potent immune effector cells that can respond to infection and cancer, as well as allowing maternal adaptation to pregnancy. In response to malignant transformation or pathogenic invasion, NK cells can secrete cytokine and may be directly cytolytic, as well as exerting effects indirectly through other cells of the immune system. To recognize and respond to inflamed or infected tissues, NK cells express a variety of activating and inhibitory receptors including NKG2D, Ly49 or KIR, CD94-NKG2 heterodimers and natural cytotoxicity receptors, as well as co-stimulatory receptors. These receptors recognize cellular stress ligands as well as major histocompatibility complex class I and related molecules, which can lead to NK cell responses. Importantly, NK cells must remain tolerant of healthy tissue, and some of these receptors can also prevent activation of NK cells. In this review, we describe the expression of prominent NK cell receptors, as well as expression of their ligands and their role in immune responses. In addition, we describe the main signaling pathways used by NK cell receptors. Although we now appreciate that NK cell biology is more complicated than first thought, there are still facets of their biology that remain unclear. These will be highlighted and discussed in this review.
Similar articles
-
Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.J Leukoc Biol. 2005 Aug;78(2):359-71. doi: 10.1189/jlb.0604360. Epub 2005 Jun 3. J Leukoc Biol. 2005. PMID: 15937142
-
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.Eur J Immunol. 1997 Jun;27(6):1374-80. doi: 10.1002/eji.1830270612. Eur J Immunol. 1997. PMID: 9209487
-
Putting the natural killer cell in its place.Immunology. 2006 Jan;117(1):1-10. doi: 10.1111/j.1365-2567.2005.02256.x. Immunology. 2006. PMID: 16423035 Free PMC article. Review.
-
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.Eur J Immunol. 2003 Jun;33(6):1657-66. doi: 10.1002/eji.200323986. Eur J Immunol. 2003. PMID: 12778484
-
Activation of natural killer cells: underlying molecular mechanisms revealed.Scand J Immunol. 2004 Jul-Aug;60(1-2):14-22. doi: 10.1111/j.0300-9475.2004.01475.x. Scand J Immunol. 2004. PMID: 15238069 Review.
Cited by
-
Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches.Front Immunol. 2016 Apr 21;7:152. doi: 10.3389/fimmu.2016.00152. eCollection 2016. Front Immunol. 2016. PMID: 27148271 Free PMC article. Review.
-
Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment.Immunotargets Ther. 2015 May 15;4:91-100. doi: 10.2147/ITT.S61292. eCollection 2015. Immunotargets Ther. 2015. PMID: 27471715 Free PMC article. Review.
-
Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells.PLoS Pathog. 2016 Jul 12;12(7):e1005733. doi: 10.1371/journal.ppat.1005733. eCollection 2016 Jul. PLoS Pathog. 2016. PMID: 27403737 Free PMC article.
-
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.Front Immunol. 2021 Apr 9;12:532484. doi: 10.3389/fimmu.2021.532484. eCollection 2021. Front Immunol. 2021. PMID: 33897679 Free PMC article.
-
Cytokine-Mediated Activation of NK Cells during Viral Infection.J Virol. 2015 Aug;89(15):7922-31. doi: 10.1128/JVI.00199-15. Epub 2015 May 20. J Virol. 2015. PMID: 25995253 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources